what is a parp inhibitor? | dana-farber cancer institute | science illustrated
Published 7 years ago • 79K plays • Length 2:47Download video MP4
Download video MP3
Similar videos
-
52:15
understanding and overcoming parp inhibitor resistance
-
47:27
parp inhibitors: a breakthrough in cancer therapy?
-
1:24
ursula matulonis explains the use of parp inhibitors for ovarian cancer
-
14:42
working at dana-farber | dana-farber cancer institute
-
1:29
what to expect when going on a parp inhibitor for ovarian cancer
-
22:15
scientist stories: dana pe'er, single-cell technologies to address fundamental questions in biology
-
7:54
pcr (polymerase chain reaction)
-
5:19
mechanisms of parp inhibition: a mode of targeted cancer treatment
-
29:51
evaluating clinical pathways for ovarian cancer treatment and maintenance therapy
-
3:44
q&a: what about parp inhibitors?
-
48:23
from variant functionality to resistance in cancer
-
3:08
what is ovarian cancer? | dana-farber cancer institute
-
47:28
parp inhibitors: a breakthrough in cancer therapy?
-
2:13
dr. elizabeth buchbinder | dana-farber cancer institute
-
1:41
dr. konstantinopoulos on rationale for topacio trial in ovarian cancer
-
2:35
welcome to dana-farber cancer institute
-
0:59
dr. campos on next steps with parp inhibitors in ovarian cancer
-
28:55
ovarinform: knowledge series featuring the advances and future scenarios in parp inhibitors
-
2:55
why do basic research in a cancer institute? | dana-farber cancer institute
-
1:58
study: oncologists and cancer gene testing | dana-farber cancer institute
-
2:11
what is an aromatase inhibitor? | dana-farber cancer institute
-
4:52
cediranib plus olaparib significantly increases pfs in recurrent ovarian cancer